Roth Capital Initiates Coverage on Guardant Health With Buy Rating

Roth Capital has initiated coverage on Guardant Health, Inc. (ticker: GH) with a 'Buy' rating and set a price target of $200 per share. This move reflects positive analyst sentiment regarding the company's position in the precision oncology market and its growth potential.